Ebola, Lassa Fever, Corona Virus (Covid-19) Pandemic Etc Respectively Curable Or Suppress Able?

Total Page:16

File Type:pdf, Size:1020Kb

Ebola, Lassa Fever, Corona Virus (Covid-19) Pandemic Etc Respectively Curable Or Suppress Able? Available Online at http://www.recentscientific.com International Journal of CODEN: IJRSFP (USA) Recent Scientific International Journal of Recent Scientific Research Research Vol. 11, Issue, 07 (C), pp. 39305-39329, July, 2020 ISSN: 0976-3031 DOI: 10.24327/IJRSR Research Article DOES HIV/AID/ SEVERE ACUTE RESPIRATORY SYNDROME (SARS), EBOLA, LASSA FEVER, CORONA VIRUS (COVID-19) PANDEMIC ETC RESPECTIVELY CURABLE OR SUPPRESS ABLE? Silas David Emmanuel1*, Barminas Jeffrey Tsware2, I.M.Bugaje, 3R, A .Damau and 4E.N. OPARA5 1,2Kaduna Polytechnic Tudun Wada Kaduna State, Nigeria 3,4National Research Institute of Chemical and Technology (NARICT), Basawa Zaria, Nigeria 5Nigerian Institute of Leather and Science Technology (NILEST), Samaru Zaria DOI: http://dx.doi.org/10.24327/ijrsr.2020.1107.5477 ARTICLE INFO ABSTRACT Article History: The unprecedented corona virus disease (COVID-19) has been duly identified as the cause of outbreaks of respiratory illness in Wuhan, Hubei province China at the beginning of December 2019 Received 6th April, 2020 th and up to date. In our case study, the general over view of the confirm cases, recovered, and death Received in revised form 15 toll were in these orders3,037605, 82959,210,842 respectively. The world Health Organization May, 2020 (WHO) has duly declared it a public Health emergency of international repute or concern. The Accepted 12th June, 2020 th method employed was primarilybased on the literaturereview approach, which was largely and Published online 28 July, 2020 qualitatively in nature and guided by scheme emerging infectious diseases by viral pandemic (Covid-19, SARS-Cov2) etc respectively. In view of our findings it was recorded USA has the Key Words: highest Covid-19 confirm cases, recovered and death toll with 987467, 111197, Coronavirus; COVID-19; SARS-CoV- 56,164respectively, followed by Spain with 209465, 232,128, 23,822respectively, Germany, Italy, 2;severe acute respiratory syndrome china have their own set back with 158,768, 117,400 ,6,136 / Italy with 192, 414, 66,624, 26977,82,862, 27610, 4,633 respectively. Nigeria in Africa has the least of all with 1,182, 222, and 35 on the27th-28thAppril2020 respectively. The studies related to preventive and control measures have been accentuated through symptom include the following; Fever, cough, Fatigue, pneumonia, headage, diarrhea, hemoptysis, dyspnea etc. respectively. Physical preventive measures were as follow: Masks, hand hygiene, practices avoidance of public contact Case detention contact tracing and quarantine etc. respectively. Other important issues have been discussed in-situ as a way to reduce transmission. Up to date no specific antiviral treatment has proven so effective; hence, infected persons are primarily relied on symptomatic treatment, suppressive and supportive care. Copyright © Silas David Emmanuel et al, 2020, this is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited. INTRODUCTION data of 2019nCoV showed that the 2019-nCoV is most closely related to two severe acute respiratory syndrome (SARS)-like In sequential to virological studies which had priorly begun CoV sequences that were isolated in bats from 2015 to 2017, ever since in 1892, the first coronavirus, avian infectious [1] suggesting that the bats’ coronaviruses and the human 2019- bronchitis virus, was isolated by Fred Beaudette in 1937 , nCoV share a common ancestor. Therefore, the 2019-nCoV can followed by severe acute respiratory syndrome coronavirus be considered as a SARS-like virus hence, the name SARS- (SARS- CoV) in 2002 and Middle East respiratory syndrome CoV-2 as designated by the Coronavirus Study Group of the coronavirus (MERS-CoV) in 2012. There are currently about International Committeeon Taxonomy of Viruses. The two bat 21, 000 deaths out of over 470,000 cases with about 82,000 viruses were collected in Zhoushan, Zhejiang Province, China, reported by china and total of over 380 000 confirmed from from 2015 to 2017. 194 countries till the 25 March 2020[2,3]. This article summarized records of index cases in Africa, the difference The new coronavirus was first isolated from stallholders who between SARS-CoV-2 and other coronaviruses in addition to worked at theSouth China Seafood Market in Wuhan. This the preventive strategies Sarbecovirus earlier reported by market also sells wild animals or mammals, which were likely Benvenuto et al.[4] and Xu et al.[5]. According to Zhang et intermediate hosts of 2019-nCoV. It hasbeen speculatedthat the al.[6], phylogenomic analysis of the recently. released genomic intermediate hosts (wild mammals) may have been sold to the *Corresponding author: Silas David Emmanuel Kaduna Polytechnic Tudun Wada Kaduna State, Nigeria International Journal of Recent Scientific Research Vol. 11, Issue, 07 (C), pp. 39305-39329, July, 2020 seafood market in Wuhan. A study by Tang et al. [7] on (ORF3b) different from that of SARS-CoVs and a secreted. populationgenetic analysesof 103 SARS-CoV-2 genomes protein that is ORF8 encoded [17]. Tang et al.[18] reported that proved that based on 2 different single nucleotide spike structure of SARS-CoV-2 has functional site variations polymorphisms that showed early complete linkage across the in the receptor-binding domain compared to viruses from viral strains submitted to the Genbank, these viruses evolved pangolin SARSr- CoVs, which could be the resultant effects into 2 major genotypes designated as L and S with the L of mutations and natural selection, enhancing viral type (~70%) found to be more prevalent than the ancestral S transmission and observable host debility In fact, Angeletti et type (~30%). al.[19] reported that it is the mutational change at positions 723 and 1010 involving the replacement of glycine amino acid In view of the current records of index cases of corona virus with serine and isoleucine by proline respectively in the in Nigeria, Germany, Spain, Italy, Iran, USA, etc respectively. ORF1ab encoded 2 (nsp2) and nsp3. Which cannot beunderestimated by any other means. For this reason, the populace of human beinghasdrastically reduced tonegativism or nothingness. Other preventive measures were taken in to recognition in situ. Chapter two literature review Aetiology and origin of sars-cov-2 Coronaviruses (CoVs) are positively sensed single-stranded RNA viruses that belong to the order Nidovirales, family Coronaviridae, subfamily Orthocoronavirinae with 4 genera: alpha, beta, delta, and gamma coronaviruses [8]. Alpha CoVs and beta CoVs originated from bats and rodents while delta CoVs andgamma CoVs have their origins from avian species[9]. The beta CoVs including SARS- CoV-1 was isolated from bats in 1992 with civet cats being the intermediary host; MERS-CoV was isolated from dome try camels in 2003; and of course, the currently circulating SARS-CoV-2 formally referred to as 2019 novel coronavirus (2019-nCoV) causing COVID-19. SARS-CoV-2 has a pleomorphic and circular structure with a Fig 1 posted protein syntheses diameter of about 60-140 nm. It can be transmitted from Diagonosis of Covid-19 human-to-human by respiratory droplets from sneezing coughing, and aerosols, with symptomatic people being the Coronaviruses have been reported to cause 5% to 10% of acute major source of transmission. It has a dynamic incubation respiratory infections with more than 2% of the population as period of about 7 to 14 days[10] The novel virus whole- healthy carriers of HCoV[20]. The clinical diagnoses are similar genome sequence showed 96.2% similarity to a bat SARS- to those of other human coronaviruses. The WHO gave a case related coronavirus isolated in China against <80% to the definition as a patient with fever and at least a symptom of genomes of SARS-CoV and <50% to MERS-CoV according cough or shortness of breath, and with no other cause that to Lu et al.[11]; Zhou et al.[12] which further confirmed the explains the symptom and history of journey to or residence similarity between the novel virus and bat betacoronavirus in of any location reporting local transmission of COVID-19 the sub-genu during the 14 days prior to symptom onset, or a patient with acute respiratory illness and having been in contact with a Sars -cov– 2 different from other coronaviruses? confirmed or probable COVID-19 case in the last 14 days SARS-COV-2, like the MERS and SARS coronaviruses, was prior to the onset ofsymptoms, or a patient case in the last 14 likely evolved from a virus previously found in animals. It days prior to the onset of symptoms, or a patient with severe infects people of all ages with evidence that older people and acute respiratory infection [fever and at least one sign/ those with underlying medical conditions are at a higher risk of symptom of respiratory disease (e.g., cough, shortness of getting severe COVID-19. unlike other coronaviruses that breath)] and requiring hospitalization and with no other a cause a significant percentage of colds in adults and children etiology that fully explains the clinical presentation. A that are not a serious threat for healthy adults[13,14]. A good probable case is a suspect case with an inconclusive testing reason could be due to high viral loads of SARS-CoV-2 that for COVID-19 while a confirmed case is a person with have been reported in the upper and lower respiratory tracts of laboratory confirmation of COVID-19 infection irrespective of patients comparing with SARS-CoV-1 hence the rate of clinical signs and symptoms[21] Laboratory diagnoses require transmission of SARS-CoV-2 is higher than that of SARS- the collection of respiratory specimens including CoV-1[15]. Also, due to the fact that no one has immunity to oropharyngeal or nasopharyngeal aspirates or washes, COVID-19, it means thousands to millions of people are likely oropharyngeal or nasopharyngeal swabs, sputum, to be more susceptible to viral infection and severe disease.
Recommended publications
  • PROTESTS and REGIME SUPPRESSION in POST-REVOLUTIONARY IRAN Saeid Golkar
    THE WASHINGTON INSTITUTE FOR NEAR EAST POLICY n OCTOBER 2020 n PN85 PROTESTS AND REGIME SUPPRESSION IN POST-REVOLUTIONARY IRAN Saeid Golkar Green Movement members tangle with Basij and police forces, 2009. he nationwide protests that engulfed Iran in late 2019 were ostensibly a response to a 50 percent gasoline price hike enacted by the administration of President Hassan Rouhani.1 But in little time, complaints Textended to a broader critique of the leadership. Moreover, beyond the specific reasons for the protests, they appeared to reveal a deeper reality about Iran, both before and since the 1979 emergence of the Islamic Republic: its character as an inherently “revolutionary country” and a “movement society.”2 Since its formation, the Islamic Republic has seen multiple cycles of protest and revolt, ranging from ethnic movements in the early 1980s to urban riots in the early 1990s, student unrest spanning 1999–2003, the Green Movement response to the 2009 election, and upheaval in December 2017–January 2018. The last of these instances, like the current round, began with a focus on economic dissatisfaction and then spread to broader issues. All these movements were put down by the regime with characteristic brutality. © 2020 THE WASHINGTON INSTITUTE FOR NEAR EAST POLICY. ALL RIGHTS RESERVED. SAEID GOLKAR In tracking and comparing protest dynamics and market deregulation, currency devaluation, and the regime responses since 1979, this study reveals that cutting of subsidies. These policies, however, spurred unrest has become more significant in scale, as well massive inflation, greater inequality, and a spate of as more secularized and violent.
    [Show full text]
  • AMERICA in the FACE of the STORM أمريكا في وجه العاصفة !! العربي األمريكي اليوم Arab American Today
    مارس 2020 م - السنة الثامنة - العدد: March 2020 - Volume : 8 - Issue :87 87 ترامب يعاند الخبراء الصحيين ويتعامل بعقلية التاجر مع كورونا Survey reveals Yemen war’s ‘devastating impact’ on child mental health اليمن يستعد لمواجهة كورونا بنظام صحي هش World Bank could deploy $150 billion over 15 months in coronavirus battle زعماء مجموعة العشرين يتعهدون بجبهة موحدة ضد كورونا “Contigen” film predicted outbreaks of Corona virus 10 years ago دراسة »متفائلة« حول فيروس كورونا الجديد AMERICA IN THE FACE OF THE STORM أمريكا في وجه العاصفة !! العربي اﻷمريكي اليوم Arab American Today EVERY PERSON In Michigan Deserves Access To Good HEALTHCARE To fund life-saving programs like MIChild, urgent care, Medicaid and Medicare YOU and YOUR FAMILY must be counted in the 2020 CENSUS this spring. The 2020 CENSUS Is quick and EASY to fi ll out. Use it to count EVERYONE in your home. And by law, it is 100% CONFIDENTIAL For more information go to www.mivoicecounts.org 002 مارس 2020 م - السنة الثامنة - العدد: WWW.ARABAMERICANTODAY.NET 87 العربي اﻷمريكي اليوم Arab American Today مع تحيات مجلة العربي اﻷمريكي اليوم 003 March 2020 - Volume : 8 - Issue :87 WWW.ARABAMERICANTODAY.NET نصوص Provision العربي اﻷمريكي اليوم Arab American Today زهرة التوليب نصف سماء كئيبة عبد الجواد العوفير* وجه إيديت عمر الشيخ * الواقع. ُسقت ثروات تلك الشعوب، ِحوربت الشتاء يطرق الباب ثقافتهم، ثم جاء فنّان ّمدع ليستبيح حقّهم يف ٍ ٍبمعطف حزين تقرير مصري صغري، أ ّﻻ تُستغلَّ مﻻمحهم. قضيت عمرا ًبالنظر إىل حياتكم، دعوتها » للجلوس هنا، عىل كأس، فهل أفتح القلب ُسقت ثرواتهم ثم جاء فنّان ّمدع ليستبيح حقّهم رميت لها كل الحلوى ﻷجذب هوسها كي يدخل الحب؟ يف تقرير ٍمصري صغري بالجمال، لكن املرارات التي سنقولها » كانت أثقل من كحول العالم..
    [Show full text]
  • Supplement RAND Appropriateness Panel to Determine The
    BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance Supplemental material placed on this supplemental material which has been supplied by the author(s) Thorax Supplement RAND appropriateness panel to determine the applicability of UK guidelines on the management of acute respiratory distress syndrome (ARDS) and other strategies in the context of the COVID-19 pandemic ǂ*Mark JD Griffiths FRCP1,2,3, *Susanna Meade MB ChB 4, *Charlotte Summers PhD5, *Danny F McAuley MD6, *Alastair G Proudfoot FRCP1,3,8, Marta Montero Baladia9, Paul Dark PhD10, Kate Diomede MB ChB11 Simon J. Finney FRCA1,3, Lui G Forni PhD12, Christopher Meadows FRCP 4, Ian A Naldrett MSc13,14, Brijesh V. Patel FFICM14,15 Gavin D. Perkins MD16, Mark A Samaan MB BS4, Laurence Sharifi FRCA9, Ganesh Suntharalingam FRCA17,18, Nicholas T Tarmey FFICM19, Matt P Wise DPhil20, Harriet F Young MRCP1, Peter M Irving MD4,7 1 Barts Heart Centre, St Bartholomew’s Hospital, London, UK. 2 National Heart & Lung Institute, Imperial College London, London, UK. 3 William Harvey Research Institute, Queen Mary University of London, London, UK. 4 Guy’s and St Thomas’ NHS Foundation Trust, London, UK. 5 Department of Medicine, School of Clinical Medicine, University of Cambridge, Cambridge, UK. 6 Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Science, Queen’s University Belfast and Regional Intensive Care Unit, Royal Victoria Hospital, Belfast UK. 7 School of Immunology and Microbial Sciences, King's College London, UK. 8 Nightingale Hospital, London, UK. 9 Barts & The London School of Anaesthesia, The Royal London Hospital, Whitechapel, London, E1 1BB, UK.
    [Show full text]
  • Update Tot 28-05-2020 1. COVID-19, Australia: Epidemiology Report 14
    Update tot 28-05-2020 1. COVID-19, Australia: Epidemiology Report 14 (Reporting week to 23:59 AEST 3 May 2020). Communicable diseases intelligence (2018). 2020;44. 2. COVID-19, Australia: Epidemiology Report 15 (Reporting week to 23:59 AEST 10 May 2020). Communicable diseases intelligence (2018). 2020;44. http://dx.doi.org/10.33321/cdi.2020.44.43. 3. Erratum: COVID-19, Australia: Epidemiology Report 14 (Reporting week to 23:59 AEST 3 May 2020). Communicable diseases intelligence (2018). 2020;44. http://dx.doi.org/10.33321/cdi.2020.44.44. 4. Metformin and COVID-19: A novel deal of an Old Drug. A.A ELA, Abdalla M. Journal of Medical Virology. 2020. 5. The mutual effects of COVID-19 and obesity. Abbas AM, Fathy SK, Fawzy AT, Salem AS, Shawky MS. Obesity Medicine. 2020;19. 6. Prognostic Value of Cardiovascular Biomarkers in COVID-19: A Review. Aboughdir M, Kirwin T, Abdul Khader A, Wang B. Viruses. 2020;12(5). 7. Clinical Course, Imaging Features, and Outcomes of COVID-19 in Kidney Transplant Recipients. Abrishami A, Samavat S, Behnam B, Arab-Ahmadi M, Nafar M, Sanei Taheri M. European Urology. 2020. 8. COVID-19 and lung cancer: risks, mechanisms and treatment interactions. Addeo A, Obeid M, Friedlaender A. J Immunother Cancer. 2020;8(1). http://dx.doi.org/10.1136/jitc-2020-000892. 9. 5-Fluorouracil in combination with deoxyribonucleosides and deoxyribose as possible therapeutic options for the Coronavirus, COVID-19 infection. Ahmad SI. Med Hypotheses. 2020;142:109754. http://dx.doi.org/10.1016/j.mehy.2020.109754.
    [Show full text]
  • COVID-19 Publications - Week 17 2021 1448 Publications
    Update April 26 - May 02, 2021, Dr. Peter J. Lansberg MD, PhD Weekly COVID-19 Literature Update will keep you up-to-date with all recent PubMed publications categorized by relevant topics COVID-19 publications - Week 17 2021 1448 Publications PubMed based Covid-19 weekly literature update For those interested in receiving weekly updates click here For questions and requests for topics to add send an e-mail [email protected] Reliable on-line resources for Covid 19 WHO Cochrane Daily dashbord BMJ Country Guidance The Lancet Travel restriction New England Journal of Medicine Covid Counter JAMA Covid forcasts Cell CDC Science AHA Oxford Universtiy Press ESC Cambridge Univeristy Press EMEA Springer Nature Evidence EPPI Elsevier Wikipedia Wiley Cardionerds - COVID-19 PLOS Genomic epidemiology LitCovid NIH-NLM Oxygenation Ventilation toolkit SSRN (Pre-prints) German (ICU) bed capacity COVID reference (Steinhauser Verlag) COVID-19 Projections tracker Retracted papers AAN - Neurology resources COVID-19 risk tools - Apps COVID-19 resources (Harvard) Web app for SARS-CoV2 mutations COVID-19 resources (McMasters) COVID-19 resources (NHLBI) COVID-19 resources (MEDSCAPE) COVID-19 Diabetes (JDRF) COVID-19 TELEMEDICINE (BMJ) Global Causes of death (Johns Hopkins) COVID-19 calculators (Medscap) Guidelines NICE Guidelines Covid-19 Korean CDC Covid-19 guidelines Flattening the curve - Korea IDSA COVID-19 Guidelines Airway Management Clinical Practice Guidelines (SIAARTI/EAMS, 2020) ESICM Ventilation Guidelines Performing Procedures on Patients With Known
    [Show full text]
  • The Coronavirus Outbreak in Iran: Political and Economic Implications
    INFO PACK The Coronavirus Outbreak in Iran: Political and Economic Implications INFO PACK The Coronavirus Outbreak in Iran: Political and Economic Implications The Coronavirus Outbreak in Iran: Political and Economic Implications © TRT WORLD RESEARCH CENTRE ALL RIGHTS RESERVED PUBLISHER TRT WORLD RESEARCH CENTRE March 2020 WRITTEN BY Merve Akın PHOTO CREDIT ANADOLU AGENCY TRT WORLD İSTANBUL AHMET ADNAN SAYGUN STREET NO:83 34347 ULUS, BEŞİKTAŞ İSTANBUL / TURKEY TRT WORLD LONDON 200 GRAYS INN ROAD, WC1X 8XZ LONDON / UNITED KINGDOM TRT WORLD WASHINGTON D.C. 1819 L STREET NW SUITE, 700 20036 WASHINGTON DC / UNITED STATES www.trtworld.com researchcentre.trtworld.com The opinions expressed in this Info Pack represent the views of the author(s) and do not necessarily reflect the views of the TRT World Research Centre. 4 The Coronavirus Outbreak in Iran: Political and Economic Implications Introduction n December 2019, China alerted the World the death and infection rate has increased severely. Health Organization (WHO) to 3l cases of an Iranian Deputy Health Minister Iraj Harirchi claims unknown virus in the city of Wuhan. By ear- that COVID-19 infects 43 Iranians and takes 3 lives ly January the situation was starting to get per hour. For its part, the WHO has asserted that the out of control and on January 7th, Chinese death toll could be potentially five times higher. Iofficials announced that they had identified a new virus, later named COVID-19 by the WHO, which Economic difficulties resulting from US sanctions belongs to the coronavirus family. The quick spread make Iran’s struggle with the coronavirus even more of the virus has created a global emergency, as con- difficult.
    [Show full text]
  • Saudi-Led G20 Summit Marks Global Turning Point in Tackling Pandemic
    UK £2 Issue 250, Year 5 March 29, 2020 EU €2.50 www.thearabweekly.com Turkish military Salafists’ Abu Dhabi crown industry buttresses opportunistic prince’s solidarity ambitions overreach towards Syria Page 16 Page 13 Page 3 Saudi-led G20 summit marks global turning point in tackling pandemic fallout Serious questions and a lot of work remain ahead for the G20 in its stewardship of the global economy. Sabahat Khan gether and cooperate in order to face this challenge.” Prospects for a coordinated world- Dubai wide health response and economic support had been marred by divi- he first virtual Group of 20 sions between the United States and summit, presided over by China over responsibility for the pan- Saudi King Salman bin Ab- demic. T dulaziz Al Saud, set the track At the end of the meeting, G20 for a global approach to tackle the leaders released a communique tell- worldwide fallout from the spread- ing the world they are prepared to do ing coronavirus pandemic but many whatever it takes to overcome coro- short- and long-term questions re- navirus pandemic. main. The G20 announced plans to inject Saudi Arabia, which assumed the $5 trillion into the global economy rotating presidency of the G20 this to preserve financial stability and year, called an extraordinary meet- revive growth by restoring confi- ing of the group and organised it in dence. The World Bank is finalising less than a week. a relief package of up to $160 billion International summits typically of its own while the United Kingdom take months of preparation — the committed $253 million towards the G20’s annual summit is scheduled international effort for finding a vac- for November in Riyadh — but the cine for coronavirus.
    [Show full text]
  • Downloaded from the Think Tank Webpage
    CENTRO STUDI PER I POPOLI EXTRA-EUROPEI “CESARE BONACOSSA” - UNIVERSITÀ DI PAVIA ASIA MAIOR The Journal of the Italian think tank on Asia founded by Giorgio Borsa in 1989 Vol. XXXI / 2020 Asia in 2020: Coping with COVID-19 and other crises Edited by Michelguglielmo Torri Nicola Mocci Filippo Boni viella Asia Maior. The Journal of the Italian Think Tank on Asia founded by Giorgio Borsa in 1989. Copyright © 2021 - Viella s.r.l. & Associazione Asia Maior ISBN 978-88-3313-827-5 (Paper) ISBN 978-88-3313-828-2 (Online) ISSN 2385-2526 (Paper) ISSN 2612-6680 (Online) Annual journal - Vol. XXXI, 2020 This journal is published jointly by the think tank Asia Maior (Associazione Asia Maior) & the CSPE - Centro Studi per i Popoli extra-europei «Cesare Bonacossa», University of Pavia Asia Maior. The Journal of the Italian Think Tank on Asia founded by Giorgio Borsa in 1989 is an open-access journal, whose issues and single articles can be freely downloaded from the think tank webpage: www.asiamaior.org. The reference year is the one on which the analyses of the volume are fo- cused. Each Asia Maior volume is always published in the year following the one indicated on the cover. Paper version Italy € 50.00 Abroad € 65.00 Subscription [email protected] www.viella.it EDITORIAL BOARD Editor-in-chief (direttore responsabile): Michelguglielmo Torri, University of Turin. Co-editors: Nicola Mocci, University of Florence. Filippo Boni, The Open University. Associate editors: Axel Berkofsky, University of Pavia; Diego Maiorano, National University of Singapore, ISAS - Institute of South Asian Studies; Giulio Pugliese, King’s College London; Emanuela Mangiarotti, University of Pavia; Pierluigi Valsecchi, University of Pavia.
    [Show full text]